Beta-secretase 1 (BACE1) inhibition improves obese and diabetic phenotypes in a leptin dependent manner

P. J. Meakin, S. M. Jalicy, S. W. Irvine, M. L. J. Ashford

    Research output: Contribution to conferencePoster

    Original languageEnglish
    Publication statusPublished - 2013
    EventDiabetes UK Professional Conference 2013 - Manchester Central Convention Complex, Manchester, United Kingdom
    Duration: 13 Mar 201315 Mar 2013
    http://www.diabetes.org.uk/Diabetes-UK-Professional-Conference-2013/

    Conference

    ConferenceDiabetes UK Professional Conference 2013
    CountryUnited Kingdom
    CityManchester
    Period13/03/1315/03/13
    Internet address

    Research Output

    • 1 Meeting abstract

    Beta-secretase 1 (BACE1) inhibition improves obese and diabetic phenotypes in a leptin dependent manner

    Meakin, P. J., Jalicy, S. M., Irvine, S. W. & Ashford, M. L. J., Mar 2013, In : Diabetic Medicine. 30, Suppl. 1, p. 41-41 1 p., P43.

    Research output: Contribution to journalMeeting abstract

    Activities

    • 2 Participation in conference

    Diabetes UK Professional Conference 2013

    Michael L. J. Ashford (Participant)

    13 Mar 201315 Mar 2013

    Activity: Participating in or organising an event typesParticipation in conference

    Diabetes UK Professional Conference 2013

    Paul Meakin (Participant)

    13 Mar 201315 Mar 2013

    Activity: Participating in or organising an event typesParticipation in conference

    Cite this

    Meakin, P. J., Jalicy, S. M., Irvine, S. W., & Ashford, M. L. J. (2013). Beta-secretase 1 (BACE1) inhibition improves obese and diabetic phenotypes in a leptin dependent manner. Poster session presented at Diabetes UK Professional Conference 2013, Manchester, United Kingdom. http://www.diabetes.org.uk/Diabetes-UK-Professional-Conference/